The perivascular niche governs an autoregulatory network to support breast cancer metastasis

Cell Biology International

Volumn 38, Issue 6, 2014, Pages 691-694

  Fazilaty, Hassan ^a   Behnam, Babak ^b,c  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b IRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c IRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Autoregulatory network; Breast cancer metastasis; Cancer stem cell; Epithelial to mesenchymal transition; Transforming growth factor beta

Indexed keywords

HERMES ANTIGEN; TRANSCRIPTION FACTOR RUNX2; TRANSCRIPTION FACTOR SLUG; TRANSCRIPTION FACTOR SOX9; TRANSFORMING GROWTH FACTOR BETA1; TRANSFORMING GROWTH FACTOR BETA2; BETA CATENIN; CELL ADHESION MOLECULE; POSTN PROTEIN, HUMAN; SNAIL FAMILY TRANSCRIPTION FACTORS; TENASCIN; THROMBOSPONDIN 1; TRANSCRIPTION FACTOR; TRANSFORMING GROWTH FACTOR BETA3;

ARTICLE; BREAST CANCER; CANCER STEM CELL; EPITHELIAL MESENCHYMAL TRANSITION; HUMAN; METASTASIS; MICROMETASTASIS; TUMOR INVASION; TUMOR MICROENVIRONMENT; TUMOR VASCULARIZATION; BIOSYNTHESIS; BREAST TUMOR; FEMALE; HOMEOSTASIS; PATHOLOGY;

BETA CATENIN; BREAST NEOPLASMS; CELL ADHESION MOLECULES; EPITHELIAL-MESENCHYMAL TRANSITION; FEMALE; HOMEOSTASIS; HUMANS; NEOPLASM METASTASIS; NEOPLASTIC STEM CELLS; TENASCIN; THROMBOSPONDIN 1; TRANSCRIPTION FACTORS; TRANSFORMING GROWTH FACTOR BETA3; TUMOR MICROENVIRONMENT;

EID: 84900795248     PISSN: 10656995     EISSN: 10958355     Source Type: Journal    
DOI: 10.1002/cbin.10261     Document Type: Article

References (24)

1. Brabletz T (2012) To differentiate or not-routes towards metastasis. Nat Rev Cancer 12: 425-36.
2. Brabletz T, Jung A, Spaderna S, Hlubek F, Kirchner T (2005) Opinion: migrating cancer stem cells-an integrated concept of malignant tumour progression. Nat Rev Cancer 5: 744-9.
3. Brown R L, Reinke L M, Damerow M S, Perez D, Chodosh L A, Yang J, Cheng C (2011) CD44 splice isoform switching in human and mouse epithelium is essential for epithelialmesenchymal transition and breast cancer progression. J Clin Invest 121: 1064-74.
4. Charafe-Jauffret E, Ginestier C, Iovino F, Wicinski J, Cervera N, Finetti P, Hur MH, Diebel ME, Monville F, Dutcher J, Brown M, Viens P, Xerri L, Bertucci F, Stassi G, Dontu G, Birnbaum D, Wicha MS (2009) Breast cancer cell lines contain functional cancer stem cells with metastatic capacity and a distinct molecular signature. Cancer Res 69: 1302-13.
5. Dingemans KP, Ramkema MD, Pals ST (2002) CD44 is exposed to the extracellular matrix at invasive sites in basal cell carcinomas. Laboratory investigation. J Tech Methods Pathol 82: 313-22.
6. Erez N (2013) Cancer: Angiogenic awakening. Nature 500: 37-8.
7. Fazilaty H, Gardaneh M, Bahrami T, Salmaninejad A, Behnam B (2013) Crosstalk between breast cancer stem cells and metastatic niche: emerging molecular metastasis pathway? Tumour biology: the journal of the International Society for. Oncodev Biol Med 34: 2019-30.
8. Fenouille N, Tichet M, Dufies M, Pottier A, Mogha A, Soo JK, Rocchi S, Mallavialle A, Galibert MD, Khammari A, Lacour JP, Ballotti R, Deckert M, Tartare-Deckert S (2012) The epithelialmesenchymal transition (EMT) regulatory factor SLUG (SNAI2) is a downstream target of SPARC and AKT in promoting melanoma cell invasion. PloS one 7: e40378.
9. Ghajar CM, Peinado H, Mori H, Matei IR, Evason KJ, Brazier H, Almeida D, Koller A, Hajjar KA, Stainier DY, Chen EI, Lyden D, Bissell MJ (2013) The perivascular niche regulates breast tumour dormancy. Nat Cell Biol 15: 807-17.
10. Gupta PB, Chaffer CL, Weinberg RA (2009) Cancer stem cells: mirage or reality. Nat Med 15: 1010-12.
11. Hanahan D, Weinberg RA (2011) Hallmarks of cancer: the next generation. Cell 144: 646-74.
12. Jordan CT, Guzman ML, NobleM(2006) Cancer stem cells. New England J Med 355: 1253-61.
13. Mani SA, Guo W, Liao MJ, Eaton EN, Ayyanan A, Zhou AY, Brooks M, Reinhard F, Zhang CC, Shipitsin M, Campbell LL, Polyak K, Brisken C, Yang J, Weinberg RA (2008) The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell 133: 704-15.
14. Naor D, Wallach-Dayan SB, Zahalka MA, Sionov RV (2008) Involvement of CD44, a molecule with a thousand faces, in cancer dissemination. Semin Cancer Biol 18: 260-7.
15. Ocana OH, Corcoles R, Fabra A, Moreno-Bueno G, Acloque H, Vega S, Barrallo-Gimeno A, Cano A, Nieto MA (2012) Metastatic colonization requires the repression of the epithelial-mesenchymal transition inducer Prrx1. Cancer Cell 22: 709-24.
16. Polyak K, Weinberg RA (2009) Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits. Nat Rev Cancer 9: 265-73.
17. Ponta H, Sherman L, Herrlich PA (2003) CD44: from adhesion molecules to signalling regulators.Nat RevMol Cell Biol 4: 33-45.
18. Scheel C, Weinberg RA (2012) Cancer stem cells and epithelialmesenchymal transition: concepts and molecular links. Semin Cancer Biol 22: 396-403.
19. Schenk S, Chiquet-Ehrismann R, Battegay EJ (1999) The fibrinogen globe of tenascin-C promotes basic fibroblast growth factor-induced endothelial cell elongation. Mol Biol Cell 10: 2933-43.
20. Siegel R, Naishadham D, Jemal A (2013) ). Cancer statistics, 2013. CA Cancer J Clin 63: 11-30.
21. Tam WL, Lu H, Buikhuisen J, Soh BS, Lim E, Reinhardt F, Wu ZJ, Krall JA, Bierie B, Guo W, Chen X, Liu XS, Brown M, Lim B, Weinberg RA (2013) Protein kinase C alpha is a central signaling node and therapeutic target for breast cancer stem cells. Cancer cell 24: 347-64.
22. Turner N, Grose R (2010) Fibroblast growth factor signalling: from development to cancer. Nat Rev Cancer 10: 116-29.
23. Weis SM, Cheresh DA (2013) A wake-up call for hibernating tumour cells. Nat Cell Biol 15: 721-3.
24. Zoller M (2011) CD44: can a cancer-initiating cell profit from an abundantly expressed molecule? Nat Rev Cancer 11: 254-67.